2013 EORTC: Epigenetic priming with SGI-110 improved antitumor activity of CTLA-4 blockade8 November 2013/in 2013, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products2013 EORTC: Epigenetic priming with SGI-110 improved antitumor activity of CTLA-4 blockade https://astx.com/wp-content/uploads/2019/11/logo_white.png 0 0 webadmin https://astx.com/wp-content/uploads/2019/11/logo_white.png webadmin2013-11-08 16:32:222016-11-25 16:32:452013 EORTC: Epigenetic priming with SGI-110 improved antitumor activity of CTLA-4 blockade
